Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial.

Sanmarti R, Pérez-García C, de-Toro FJ, Salvador G, Escudero-Contreras A, Cuervo A, Graell E, Reina D, Kanterewicz E, Corominas H, Urionaguena-Onaindia I, López-Lasanta M, Olivé A, Sala-Gómez M, Frade-Sosa B, Morlà-Novell RM, Polino L, Meraz-Ostiz JA, Oreiro N, Blanco FJ, Pérez-Nadales I, Ortega-Castro R, Busquets-Pérez N, Gómez-Centeno AD, Camacho O, Rodríguez-Cros JR, Millan-Arciniegas AM, García-Llorente JF, Borrell H, Prior-Español Á, Castell-Quiñones S, Cruceta A, Bonfill E, Domenech-Gómez G, Roca-Fàbregas A, Ríos J, Tobalina-Maestre L, Gómara MJ, Haro I

Open source

DOI
10.1038/s41591-026-04395-6
Published
2026 Jul
Container
Nature medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04395-6,
  title = {Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial.},
  author = {Sanmarti R and Pérez-García C and de-Toro FJ and Salvador G and Escudero-Contreras A and Cuervo A and Graell E and Reina D and Kanterewicz E and Corominas H and Urionaguena-Onaindia I and López-Lasanta M and Olivé A and Sala-Gómez M and Frade-Sosa B and Morlà-Novell RM and Polino L and Meraz-Ostiz JA and Oreiro N and Blanco FJ and Pérez-Nadales I and Ortega-Castro R and Busquets-Pérez N and Gómez-Centeno AD and Camacho O and Rodríguez-Cros JR and Millan-Arciniegas AM and García-Llorente JF and Borrell H and Prior-Español Á and Castell-Quiñones S and Cruceta A and Bonfill E and Domenech-Gómez G and Roca-Fàbregas A and Ríos J and Tobalina-Maestre L and Gómara MJ and Haro I},
  year = {2026},
  journal = {Nature medicine},
  doi = {10.1038/s41591-026-04395-6},
  url = {https://doi.org/10.1038/s41591-026-04395-6}
}

RIS

TY  - JOUR
TI  - Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial.
AU  - Sanmarti R
AU  - Pérez-García C
AU  - de-Toro FJ
AU  - Salvador G
AU  - Escudero-Contreras A
AU  - Cuervo A
AU  - Graell E
AU  - Reina D
AU  - Kanterewicz E
AU  - Corominas H
AU  - Urionaguena-Onaindia I
AU  - López-Lasanta M
AU  - Olivé A
AU  - Sala-Gómez M
AU  - Frade-Sosa B
AU  - Morlà-Novell RM
AU  - Polino L
AU  - Meraz-Ostiz JA
AU  - Oreiro N
AU  - Blanco FJ
AU  - Pérez-Nadales I
AU  - Ortega-Castro R
AU  - Busquets-Pérez N
AU  - Gómez-Centeno AD
AU  - Camacho O
AU  - Rodríguez-Cros JR
AU  - Millan-Arciniegas AM
AU  - García-Llorente JF
AU  - Borrell H
AU  - Prior-Español Á
AU  - Castell-Quiñones S
AU  - Cruceta A
AU  - Bonfill E
AU  - Domenech-Gómez G
AU  - Roca-Fàbregas A
AU  - Ríos J
AU  - Tobalina-Maestre L
AU  - Gómara MJ
AU  - Haro I
PY  - 2026
JO  - Nature medicine
DO  - 10.1038/s41591-026-04395-6
UR  - https://doi.org/10.1038/s41591-026-04395-6
ER  -

APA

R, S., C, P., FJ, D., G, S., A, E., A, C., E, G., D, R., E, K., H, C., I, U., M, L., A, O., M, S., B, F., RM, M., L, P., JA, M., N, O., FJ, B., I, P., R, O., N, B., AD, G., O, C., JR, R., AM, M., JF, G., H, B., Á, P., S, C., A, C., E, B., G, D., A, R., J, R., L, T., MJ, G., & I, H. (2026). Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial.. Nature medicine. https://doi.org/10.1038/s41591-026-04395-6

Source records